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Abstract: Glycation is associated with several neurodegenerative disorders, including Alzheimer’s
disease (AD), where it potentiates the aggregation and toxicity of proteins such as β-amyloid (Aβ).
Published studies support the anti-glycation and neuroprotective effects of several polyphenol-rich
fruits, including berries, which are rich in anthocyanins. Herein, blackberry, black raspberry,
blueberry, cranberry, red raspberry, and strawberry extracts were evaluated for: (1) total phenolic
and anthocyanins contents, (2) free radical (DPPH) scavenging and reactive carbonyl species
(methylglyoxal; MGO) trapping, (3) anti-glycation (using BSA-fructose and BSA-MGO models),
(4) anti-Aβ aggregation (using thermal- and MGO-induced fibrillation models), and, (5) murine
microglia (BV-2) neuroprotective properties. Berry crude extracts (CE) were fractionated to yield
anthocyanins-free (ACF) and anthocyanins-enriched (ACE) extracts. The berry ACEs (at 100 µg/mL)
showed superior free radical scavenging, reactive carbonyl species trapping, and anti-glycation
effects compared to their respective ACFs. The berry ACEs (at 100 µg/mL) inhibited both thermal-
and MGO-induced Aβ fibrillation. In addition, the berry ACEs (at 20 µg/mL) reduced H2O2-induced
reactive oxygen species production, and lipopolysaccharide-induced nitric oxide species in BV-2
microglia as well as decreased H2O2-induced cytotoxicity and caspase-3/7 activity in BV-2 microglia.
The free radical scavenging, reactive carbonyl trapping, anti-glycation, anti-Aβ fibrillation, and
microglial neuroprotective effects of these berry extracts warrant further in vivo studies to evaluate
their potential neuroprotective effects against AD.
Keywords: berry anthocyanins; glycation; neuroprotection; beta amyloid; oxidative stress;
Alzheimer’s disease
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1. Introduction
Glycation is a non-enzymatic process which starts with a reaction between sugar molecules and
the free amino groups of proteins to produce unstable aldimine and ketoamine structures. Over time,
these structures can then transform to a heterogenous group of compounds collectively known as
advanced glycation endproducts (AGEs). Recently, it has been proposed that AGEs may contribute
to the pathogenesis of several neurodegenerative diseases including Alzheimer’s disease (AD) [1].
In AD patients, significantly elevated levels of AGEs have been reported in neurons, astroglia, and
cerebrospinal fluid [2]. Moreover, clinical studies have shown that subjects with higher circulatory
levels of AGEs have a faster rate of cognitive decline [3].
Based on previous research findings, two major mechanisms have been proposed to link AGEs
and AD, namely, (1) AGEs-induced oxidative stress, and, (2) reactive carbonyl species (RCS)-induced
carbonyl stress [4]. Accumulated AGEs can magnify the production of reactive oxygen species (ROS)
by binding to transmembrane receptors known as RAGE (receptor for AGEs), triggering intracellular
signaling pathways, and stimulating the production of cytokines, which leads to neuronal oxidative
stress, inflammation, and apoptosis. In addition, RCS, such as the active metabolic intermediate,
methylglyoxal (MGO), can react rapidly with proteins to produce AGEs. These AGEs precursors exert
direct cytotoxicity to neuronal cells by inducing the cross-linking of the beta amyloid (Aβ) protein and
enhancing the formation of insoluble Aβ deposits, a pathological hallmark of AD. Moreover, ROS
and RCS can also mediate cellular oxidative and inflammatory stresses, leading to the dysfunction
of neuronal cells which greatly contributes towards the development of neurodegenerative diseases
including AD [4,5].
Over the past years, our research group has been interested in the anti-AGEs effects of medicinal
plants including plant foods and their derived extracts and pure compounds [6–11]. As part of
this research program, we proposed an algorithm to predict the potential neuroprotective effects of
traditional Ayurvedic medicinal plant extracts against AD using anti-glycation, anti-Aβ-fibrillation,
and anti-neuroinflammatory bioassays [12]. In that project, we reported that the medicinal plant
extracts which contained a high phenolic content, and showed free radical scavenging, RCS trapping,
anti-glycation, anti-Aβ-fibrillation, and anti-neuroinflammatory properties were promising candidates
for AD based research [12]. Given these observations [12], herein, we sought to similarly evaluate six
common edible berries, which are particularly rich in polyphenols, including anthocyanins, in this
panel of bioassays. Anthocyanins are the water-soluble pigments responsible for the colors of berries
and have been extensively studied and implicated in the numerous biological effects and potential
health benefits of these fruits [13].
Berry fruits have been reported to show anti-glycation [14] and potential neuroprotective
properties [15,16]. Several wild berries, collected from northern Quebec in Canada, were recently
reported to show anti-glycation activities which correlated with their antioxidant activities and
total phenolic contents [17]. However, to date, there are limited studies linking the anti-glycation
effects to the potential neuroprotective properties of common edible berries, namely, blackberry
(Rubus sp.), black raspberry (Rubus occidentalis), blueberry (Vaccinium angustifolium), cranberry
(Vaccinium macrocarpon), red raspberry (Rubus idaeus), and strawberry (Fragaria ananassa). The
phenolic composition, including the identification of the individual anthocyanins in these berries
have been extensively investigated [18–23]. Moreover, studies have shown that the synergistic,
additive, and/or complementary effects of multiple constituents within whole plant foods and their
extracts show biological effects greater than any single constituent alone [24]. Therefore, taking this
“whole food/extract” approach, herein, we aimed to evaluate the aforementioned berry extracts
(crude extracts, CEs; anthocyanins-enriched extracts, ACEs; anthocyanins-free extracts, ACFs) for:
(1) total phenolic and anthocyanins contents, (2) free radical (DPPH) scavenging and reactive carbonyl
(MGO) species trapping properties, (3) anti-glycation effects (BSA-fructose and BSA-MGO models),
(4) anti-Aβ-fibrillation effects (thermal- and MGO-induced), and (5) microglial (BV-2) neuroprotective
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properties. This is the first study to evaluate the ACFs and ACEs of these six edible berries in this
panel of bioassays.
2. Results
2.1. Total Phenolic and Anthocyanins Contents of Berry Extracts
Each berry crude extract (CE) was fractionated by XAD-16 resin adsorption chromatography
as previously reported [25] to yield anthocyanins-free (ACFs) and anthocyanins-enriched (ACEs)
extracts after solvent removal in vacuo. The chemical constituents of these berry extracts have been
previously characterized by our group using high performance liquid chromatography with ultraviolet
(HPLC-UV) and electrospray ionization mass spectrometry (HPLC-ESI-MS) methods and the major
phenolic compounds identified were anthocyanins, flavonols, flavanols, ellagitannins, gallotannins,
proanthocyanidins, and phenolic acids [26]. In the current study, we confirmed the identities of the
individual anthocyanins (as shown in Table 1) in each berry ACEs by conducting HPLC-UV analyses
and by comparison of the elution orders and their retention times based on our previous report [26].
The chromatograms for each of the berry ACEs (Supplementary Materials Figures S1A–S6A shown at
520 nm, the characteristic wavelength of anthocyanins), confirmed the presence of anthocyanins (as
shown in Table 1) which were in agreement with literature [26]. In addition, the HPLC chromatograms
of the berry ACEs were extracted at a wavelength of 280 nm (see Supplementary Materials Figures
S1B–S6B) supporting the presence of other phenolic “non-anthocyanin” phytochemicals in the berry
ACEs including hydrolyzable and condensed tannins (such as ellagitannins, gallotannins, and
proanthocyanidins), flavonols, stilbenes, phenolic acids, etc. Other “non-phenolic” constituents
including carbohydrates (oligosaccharides and polysaccharides), vitamins, and minerals have also
been reported from several of these berries (see the summary of berry constituents in Supplementary
Materials Table S1).
Table 1. Anthocyanins reported in the six edible berry extracts.
Berry Sample Anthocyanins
Blackberry cyanidin-3-O-glucoside, cyanidin-3-O-arabinoside, cyanidin-3-O-xyloside,cyanidin-3-O-malonylglucoside, and cyanidin-3-O-dioxalylglucoside
Black raspberry cyanidin-3-O-sambuoside, cyanidin-3-O-glucoside,cyanidin-3-O-xylosylrutinoside, and cyanidin-3-O-rutinoside
Blueberry
cyanidin-3-O-galactoside, petunidin-3-O-galactoside,
petunidin-3-O-glucoside, peonidin-3-O-galactoside, and
malvidin-3-O-glucoside
Cranberry cyanidin-3-O-galactoside, cyanidin-3-O-arabinoside,peonidin-3-O-galactoside, and peonidin-3-O-arabinoside
Red raspberry cyanidin-3-O-glucoside, cyanidin-3-O-arabinoside, anddelphinidin-3-O-arabinoside
Strawberry cyanidin-3-O-glucoside, pelargonidin-3-O-glucoside, andpelargonidin-3-O-rutinoside
The CEs, ACFs, and ACEs for each berry were evaluated for their total polyphenol contents.
As shown in Table 2, the berry ACEs and CEs had polyphenol contents ranging from 5.8–11.3%, and
4.1–9.8%, based on gallic acid equivalents (GAEs), respectively. The berry ACFs had lower polyphenol
contents (ranging from 0.3–1.5%). The CEs and ACEs were then further evaluated for their total
anthocyanins contents based on cyanidin-3-O-glucoside equivalents (Table 2). As expected, the berry
ACEs contained higher levels of anthocyanins as compared to their respective CEs with the highest
values observed for blackberry (6.3% vs. 2.8%), black raspberry (5.7% vs. 2.8%), and red raspberry
(5.6% vs. 4.2%).
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Table 2. Berry extracts and their total phenolic and total anthocyanins contents.
Common Name Species Family Extract a PhenolicContent b
Anthocyanins
Content c
Blackberry Rubus sp. Rosaceae
CE 6.8% 2.8%
ACE 11.3% 6.3%
ACF 0.3% n.d.d
Black raspberry Rubus occidentalis Rosaceae
CE 4.1% 2.8%
ACE 7.5% 5.7%
ACF 0.3% n.d.
Blueberry Vaccinium angustifolium Ericaceae
CE 9.8% 2.5%
ACE 8.5% 4.4%
ACF 1.5% n.d.
Cranberry Vaccinium macrocarpon Ericaceae
CE 7.7% 1.2%
ACE 6.4% 3.8%
ACF 1.3% n.d.
Red raspberry Rubus idaeus Rosaceae
CE 6.4% 4.2%
ACE 5.8% 5.6%
ACF 0.9% n.d.
Strawberry Fragaria ananassa Rosaceae
CE 3.8% 2.2%
ACE 7.3% 3.7%
ACF 0.8% n.d.
a CE: crude extract; ACE: anthocyanins-enriched extract; ACF: anthocyanins-free extract; b value expressed
as in w/w% of gallic acid equivalents; c value expressed as in w/w% of cyanidin-3-O-glucoside equivalents;
d n.d. = not detected.
2.2. Berry Extracts Scavenge Free Radicals in the DPPH Assay
The free radical scavenging capacities of the berry samples were determined using the DPPH
assay. Overall, the free radical scavenging capacities of the ACEs and CEs were superior to the ACFs
(Table 3). The highest free radical scavenging capacity among the CEs was observed for red raspberry
with an IC50 value of 268.5 µg/mL while the other CEs had activities with IC50 values ranging
from 381.1–2865.9 µg/mL. Among the ACEs, blackberry had the highest free radical scavenging
activity with an IC50 value of 133.8 µg/mL while the other ACEs also showed free radical scavenging
activity with IC50 values ranging from 337.7–469.8 µg/mL. Among the ACFs, those from blueberry,
cranberry, and red raspberry, showed moderate free radical scavenging effects with IC50 values
ranging from 2010.3–2598.5 µg/mL, which were higher than butylated hydroxytoluene (BHT), and
ascorbic acid, used as the positive controls (IC50 = 727.8 and 12.3 µg/mL, respectively) [27]. The
free radical scavenging activity of these ACFs suggests the presence of “non-anthocyanins phenolic”
constituents in these extracts. Indeed, based on previous studies from our laboratory and other research
groups, berries are known to contain a wide variety of “non-anthocyanins phenolic” compounds
including other flavonoids (flavonols and flavanols), phenolic acids, stilbenoids, hydrolysable tannins
(ellagitannins and gallotannins), and condensed tannins (proanthocyanidins) [28,29].
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Table 3. Free radical scavenging capacity (DPPH assay) and reactive carbonyl species (MGO)
scavenging capacity of berry extracts.
Berry Extracts
Free Radical
Scavenging Capacity
(IC50; µg/mL)
MGO Trapping
Capacity (%)
Blackberry
CE 1968.6 ± 22.3 13.7
ACE 133.8 ± 11.1 30.3
ACF n.d. a 3.3
Black raspberry
CE 2865.9 ± 62.8 21.8
ACE 409.6 ± 23.7 31.1
ACF n.d. 8.4
Blueberry
CE 381.1 ± 3.1 15.6
ACE 454.3 ± 4.6 29.2
ACF 2598.5 ± 34.7 n.d.
Cranberry
CE 392.6 ± 2.9 10.1
ACE 434.5 ± 7.1 32.8
ACF 2217.3 ± 11.1 18.4
Red raspberry
CE 268.5 ± 8.6 13.7
ACE 337.7 ± 1.6 18.2
ACF 2010.3 ± 60.2 9.4
Strawberry
CE n.d. 14.5
ACE 469.8 ± 2.5 16.2
ACF n.d. n.d.
BHT b 727.8 ± 11.6 n.t.d
Ascorbic acid b 12.3 ± 1.7 n.t.
AG c n.t. 73.7
a n.d. = not detected; b Butylated hydroxytoluene (BHT) and ascorbic acid, positive controls for DPPH assay;
c Aminoguanidine (AG), positive control for MGO trapping assay; d n.t. = not tested.
2.3. Berry Extracts Scavenge Reactive Carbonyl Species (RCS)
The RCS scavenging capacities of the berry extracts (CEs, ACFs, ACEs; all at 100 µg/mL) are
presented as the trapping capacity of methylglyoxal (MGO). As shown in Table 3, similar to the DPPH
free radical scavenging assay, the ACEs had superior MGO trapping capacity ranging from 16.2–32.8%
while the CEs showed RCS trapping capacity ranging from 10.1–21.8%. Moderate MGO-trapping
capacity was observed for the ACFs of cranberry, red raspberry, and black raspberry (18.4%, 9.4%,
and 8.4%, respectively). The other ACFs showed weak MGO-trapping capacity (up to 3.3%). The
positive control, aminoguanidine (AG), a synthetic anti-glycation agent, at equivalent concentration of
100 µg/mL, showed 73.7% MGO-trapping capacity.
2.4. Berry Extracts Inhibit the Formation of AGEs
In the fructose-induced AGEs formation assay (Figure 1A), at a concentration of 100 µg/mL,
the berry ACEs showed the most potent anti-glycation effects followed by their corresponding CEs
and ACFs. Among all of the berry ACEs, black raspberry showed the highest inhibitory effects
(85.4%), followed by cranberry (74.5%), blueberry (66.7%), blackberry (66.1%), red raspberry (59.1%),
and strawberry (42.8%). In the MGO-induced AGEs formation assay, at the same concentration
(100 µg/mL), only the ACEs from black raspberry, blueberry, blackberry, and cranberry showed
moderate inhibitory effects of 40.5%, 29.2%, 27.7%, and 25.4%, respectively. Therefore, a higher
concentration (500 µg/mL) of these extracts was selected for further evaluation. As shown in
Figure 1B, at this higher concentration, the berry ACEs showed the highest inhibitory effects ranging
from 42.3–74.6%, followed by their respective CEs and ACFs. Among the ACEs, the most potent
anti-glycation effects were from black raspberry (74.8%), blueberry (72.4%) and blackberry (72.2%).
The other berry ACEs showed anti-glycation effects ranging from 42.4–51.7% inhibition.
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Figure 1. Berry extracts (crude extracts (CEs), anthocyanins-enriched (ACE), and anthocyanins-free
(ACF)) were evaluated for their inhibitory effects on the formation of AGEs. The berry extracts were
assayed at concentrations of 100 and 500 µg/mL for the BSA-fructose assay (A) and BSA-MGO assay
(B), respectively. Berry extracts were incubated at 37 ◦C for 21 days for the BSA-fructose assay and
7 days for the BSA-MGO assay. Data are presented as means ± SDs of three independent experiments.
2.5. Berry Anthocyanin-Enriched Extracts (ACEs) Inhibit Aβ Fibrillation
The berry ACEs had higher phenolic and anthocyanins contents and stronger activities in the free
radical scavenging, MGO-trapping, and anti-glycation assays, as compared to their respective CEs
and ACFs. Therefore, the berry ACEs were further selected to evaluate their potential neuroprotective
effects. The berry ACEs were first evaluated for their anti-Aβ fibrillation effects using two different
conditions, thermal-induced and MGO-induced fibrillation of Aβ. In the thermal-induced Aβ
fibrillation assay (Figure 2B), all of the berry ACEs (at 400 µg/mL) showed comparable inhibitory
effects ranging from 80% to 89%. Cranberry showed the highest activity (89.2%), followed by
blackberry (87.8%), black raspberry (86.3%), blueberry (85.1%), strawberry (81.7%), and raspberry
(80.4%). Resveratrol (RESV), used as the positive control, showed similar inhibitory effects (79.6%) at
a concentration of 100 µg/mL. At the lower test concentration of 100 µg/mL (Figure 2A), the berry
ACEs also inhibited Aβ fibrillation ranging from 47–74%. Among all of the berries, blackberry showed
the highest inhibitory effect of 74% followed by blueberry (73.6%), and black raspberry (71.5%) which
were comparable to RESV (79.7%) at equivalent concentrations of 100 µg/mL.
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A similar trend was observed in the MGO-induced Aβ fibrillation assay as for the thermal-induced
assay ( 2C, D). At the higher test concentration of 400 µg/mL, all of the berry ACEs showed similar
inhibitory levels ranging from 77–88%. Cranberry, showed the highest inhibitory effect of 88.2%,
followed by red raspberry (84.5%), black raspberry (83.1%), blueberry (82.7%), blackberry (82.3%), and
strawberry (77.5%). At the lower test concentration of 100 µg/mL, all of the ACEs showed slightly
lower inhibitory levels ranging from 61–74%. These inhibitory levels were significantly higher than
aminoguanidine (AG; 31.6% inhibition), a synthetic MGO trapping agent, used as a positive control,
which was evaluated at an equivalent concentration of 100 µg/mL.
2.6. Berry Anthocyanin-Enriched Extracts (ACEs) Reduce LPS-Induced Inflammation in BV-2 Microglia
While anthocyanins-rich fruits, including açai and blueberry, have been reported to show
anti-neuroinflammatory effects in BV-2 microglia [30–32], there are limited studies conducted with
the other aforementioned edible berries in these cells. Therefore, the berry ACEs were evaluated
for potential protective effects against inflammatory stress in BV-2 microglia. The berry ACEs were
first evaluated for their effects on BV-2 cell viability at three different concentrations of 20, 40, and
80 µg/mL. As shown in Figure 3, the berry ACEs at the lowest test concentration (20 µg/mL) were
non-toxic to the BV-2 cells (cell viability > 95%) and, therefore, this concentration was selected for
further biological evaluations.
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using the CTG 2.0 cell viability assay. Statistical significance was reported as p ≤ 0.01 as **, and
p ≤ 0.0001 as ****, as compared to the control group.
As sh wn in Figure 4, after induction of inflammat on by lipopolysaccharide (LPS), the levels
of nitric oxide species (NOS) in LPS treated BV-2 microglia were elevated by 15-fold compared to
control cells. All of the berry ACEs (at 20 µg/mL) significantly reduced LPS-induced NOS production
in BV-2 microglia. The highest levels of NOS reduction were observed for the ACEs of cranberry
(36.5%), strawberry (34.1%), blackberry (27.0%), black raspberry (26.0%), red raspberry (23.6%), and
blueberry (17.3%).
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Figure 4. Berry ACEs were evaluated for their inhibitory effects on the production of nitric oxide
species (NOS) in murine BV-2 microglia using the Griess reagent. BV-2 microglia were pre-treated
with berry ACEs (at 20 µg/mL) for 1 h and inflammatory stress was induced by treatment with
lipopolysaccharide (LPS; at 1 µg/mL) for 23 h. Data are presented as means± SDs with three replicates.
Statistical si nificance was reported as p ≤ 0.001 as ***, and p ≤ 0.0001 as ****, as compared to the
LPS-treated group.
2.7. Berry Anthocyanin-Enriched Extracts (ACEs) H2O2-Induced Oxidative Stress in BV-2 Microglia
Next, we evaluated whether the berry ACEs were able to decrease oxidative stress in BV-2
microglia. As shown in Figure 5, when oxidative stress was induced by H2O2, the levels of reactive
oxygen species (ROS) in the H2O2-treated BV-2 cells increased by 24.2% as compared to control cells.
The berry ACEs (at 20 µg/mL) reduced ROS production in the BV-2 microglia up to 12.3% as compared
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to cells exposed to H2O2 alone. The ACE of red raspberry showed the highest ROS reduction of 12.3%
while the ACEs of blackberry, cranberry, and strawberry showed comparable ROS reduction of 11.5%,
9.2%, and 10.8%, respectively.
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Figure 5. Berry ACEs were evaluated for their inhibitory effects on the production of reactive oxygen
species (ROS) in murine BV-2 microglia using the fluorescent probe, DCFDA. BV-2 microglia were
incubated with each berry ACEs (at 20 µg/mL) for 24 h and then with media containing the DCFDA
reagent (20 µM) for 30 min. Oxidative stress was induced by the treatment with hydrogen peroxide
(H2O2; at 100 µM). Data are presented as means ± SDs with three replicates. Statistical significance
was reported as the following: p ≤ 0.01 as **, p ≤ 0.001 as *** and p ≤ 0.0001 as ****, as compared to the
H2O2-treated group.
2.8. Berry Anthocyanin-Enriched Extracts (ACEs) Protect BV-2 Microglia against H2O2-Induced Cytotoxicity
The neuroprotective effects of the berry ACEs were further evaluated in BV-2 microglia against
H2O2-induced cytotoxicity as previously reported [12]. As shown in Figure 6, the cell viability of
H2O2 (100 µM)-treated BV-2 cells was reduced by 26.7% as compared to control cells. After treatment
with the ACEs of blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry (at
20 µg/mL), the viabilities of H2O2 challenged BV-2 microglia were increased by 14.7%, 23.4%, 10.4%,
18.7%, 13.8%, and 18.6%, respectively, as compared to the H2O2 treatment group.
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Figure 6. Berry ACEs were evaluated for the protective effects in murine BV-2 microglia. BV-2 microglia
were incubated with each berry ACEs (at 20 µg/mL) for 24 h and then cytotoxicity was induced by
treatment with hydrogen peroxide (H2O2; at 100 µM). After 6 h incubation, cellular viability was
determined by the CTG 2.0 assay. Data are presented as means ± SDs with three replicates. Statistical
significance was reported as the following: p ≤ 0.05 as *, p ≤ 0.01 as **, p ≤ 0.001 as *** and p ≤ 0.0001
as ****, as compared to the H2O2-treated group.
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2.9. Berry Anthocyanin-Enriched Extracts (ACEs) Decrease H2O2-Induced Activity of Caspase-3/7 in
BV-2 Microglia
Microglia death induced by oxidative stress is highly associated with a group of cysteinyl-
aspartate-specific proteases including caspase-3/7 [33]. To further evaluate whether the microglia
neuroprotective effects of the berry ACEs are mediated by regulation of caspase-3/7, we measured
caspase-3/7 activity in BV-2 cells treated with the berry ACEs. As shown in Figure 7, the
activity of caspase-3/7 in BV-2 cells exposed to oxidative stress (by treatment of H2O2 at 100 µM)
increased by 69.9% as compared to the control group. The ACEs for blackberry, black raspberry,
cranberry, red raspberry, and strawberry (at concentrations of 20 µg/mL) significantly decreased
caspase-3/7 activities by 35.5%, 40.7%, 46.3%, 54.9%, and 46.9%, respectively, as compared to the H2O2
treatment group.
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Figure 7. Berry ACEs were evaluated for their inhibitory effects on caspase-3/7 activity in BV-2
microglia treated with hydrogen peroxide (H2O2; at 100 µM). Cells were pre-treated with 20 µg/mL of
berry ACEs for 24 h, then treated with H2O2 for 6 h. Data are presented as means ± SDs with three
replicates. Statistical significance was reported as p ≤ 0.01 as **, p ≤ 0.0001 as ****, as compared to the
H2O2-treated group.
3. Discussion
Alzheimer’s disease (AD) is a neurodegenerative disorder linked with oxidative damage and
inflammation and despite considerable research into understanding the pathology of this disease, there
are still no drugs which can reverse its progression. Natural products, including polyphenolic-enriched
extracts from functional foods, show promise as dietary agents for the prevention and potential
management of AD [34–36]. Published data suggest that the neuroprotective effects of berry fruits
are associated with their polyphenolic compounds, particularly, anthocyanins [37,38]. For instance,
anthocyanins have been reported to protect against inflammatory and oxidative stress mediated
neuroinflammation and neurodegeneration in adult mouse cortex [39], as well as in brains of postnatal
rats [40], and rats fed a high-fat diet [41]. In light of these data, we designed the current study to
evaluate the potential neuroprotective effects of polyphenolic-enriched extracts of six common edible
berries, namely, blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry. To
investigate whether anthocyanins were indeed the major contributors to the neuroprotective effects of
these berries, we prepared anthocyanins-free (ACFs) and anthocyanins-enriched (ACEs) extracts from
each crude berry extract for biological evaluation.
Overall, the berry ACEs had higher total polyphenol and anthocyanins contents and showed
superior antioxidant, MGO trapping, and anti-glycation activities compared to their respective CEs
and ACFs. Notably, when protein glycation was induced by MGO, a reactive AGEs precursor, the berry
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ACEs showed superior inhibitory effects against the formation of AGEs (Figure 1B) compared to their
respective CEs and ACFs, which was in agreement with their superior MGO trapping capacity (Table 3).
Anthocyanins, including delphinidin-3-rutinoside and cyanidin-3-O-rutinoside from blackcurrant
berry extract have been previously reported to trap MGO by forming anthocyanins-mono-MGO
adducts [42]. Similarly, the anthocyanin, cyanidin-3-O-rutinoside, has also been reported to inhibit
MGO-induced glycation via its carbonyl trapping ability [43]. Therefore, the superior activities of the
ACEs compared to their respective CEs and ACFs suggested that anthocyanins were indeed major
contributors to the overall biological activities of these berries.
While the overall trend for most of the berries showed superior anti-AGE effects of their ACEs
compared to their respective CEs and ACFs, blueberry CE was slightly more active than its ACE
in the fructose-BSA assay. This suggests that other “non-anthocyanin phenolic” constituents in the
blueberry CE, such as catechins and proanthocyanidins, could also possibly contribute to its overall
anti-glycation activity as has been previously reported [44]. Also, in general, the berry ACFs were less
active in the MGO-trapping and anti-glycation assays as compared to their respective ACEs. However,
it is interesting to note that the ACF of cranberry also showed inhibition of fructose-induced AGEs
formation (39.0%) and MGO-trapping capacity (18.4%) suggesting that there are ‘non-anthocyanins’
constituents in this berry which may also play a role in its biological effects. Indeed, it has previously
been reported that procyanidin oligomers present in water fractions of cranberry show anti-glycation
and MGO trapping activities [45]. In addition, our group has also reported that oligosaccharides
isolated from an aqueous extract of cranberry showed inhibitory effects on the formation of AGEs
by scavenging free radicals and not through an MGO-trapping mechanism [10]. Therefore, although
anthocyanins may play an important role in the observed biological activities of the berry extracts in
this selected panel of bioassays, other non-anthocyanin constituents, such as found in blueberry and
cranberry, may also contribute to the overall activities of these fruits through additive, complementary,
and/or synergistic effects.
Given that the berry ACEs were superior in the above assays as compared to their respective
ACFs and CEs, these samples were selected for further biological evaluation in AD-based assays.
The berry ACEs were first assessed for their inhibitory effects on the fibrillation of Aβ peptides, the
abnormal accumulation and deposition of which is regarded as a diagnostic hallmarker of AD. We
used the ThT binding assay to assess both thermal-induced (using resveratrol as positive control) and
MGO-induced (using aminoguanidine as a positive control) fibrillation of Aβ. As shown in Figure 2,
all of the berry ACEs showed anti-Aβ fibrillation activities in a concentration dependent manner at
100 and 400 µg/mL. In the thermal-induced Aβ fibrillation assay, the berry ACEs showed comparable
activity as resveratrol at an equivalent concentration of 100 µg/mL (Figure 2A). However, in the
MGO-induced Aβ fibrillation assay, the berry ACEs showed superior activities to aminoguanidine
at an equivalent concentration of 100 µg/mL (Figure 2C Although our observations with the berry
ACEs are in agreement with published reports on the known Aβ fibrillation inhibitory effects of
polyphenols [46,47], a major limitation of the current study lies in the test concentrations used in
these in vitro experiments which are not translatable to the in vivo situation. The bioavailability of
anthocyanins is generally low [48,49] although their levels in berry fruits can range from 10 s to 100 s
of milligrams per serving [48].
Next, we evaluated the potential neuroprotective effects of the berry ACEs in cellular based
assays. The effects of the berry ACEs on murine BV-2 microglia was assessed and a non-cytotoxic
concentration (20 µg/mL; Figure 3) was selected for further evaluation. At this concentration, the
berry ACEs decreased LPS-induced production of NOS and H2O2-induced production of ROS in BV-2
microglia (Figures 4 and 5, respectively). This suggested that the berry ACEs reduced inflammatory and
oxidative stresses in BV-2 microglia which is in agreement with similar effects reported for anthocyanins
from other berries such as açai and blueberry [30–32]. Apart from their anti-inflammatory effects, their
antioxidant effects may also be another plausible mechanism that contributes to the overall microglial
neuroprotection of the berry ACEs in BV-2 cells. Indeed, the berry ACEs reduced the production of
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cellular ROS and increased the viability of BV-2 cells (Figures 5 and 6, respectively), suggesting that
the berry ACEs were able to ameliorate oxidative stress induced damage in BV-2 cells. This effect
was further supported by examination of a cysteinyl-aspartate protease, namely, caspase-3/7, in BV-2
cells (Figure 7). Caspase-3/7 serves as an executioner protease when cells are undergoing apoptosis
via the intrinsic (oxidative stress) or extrinsic (ligand–death receptor) pathways. During this process,
caspase-3/7 is able to cleave a variety of proteins associated with cell DNA repairing and proliferation.
Therefore, our findings showed that the berry ACEs were able to maintain BV-2 cell viability against
oxidative stress by downregulation of caspase-3/7 activity. This is in agreement with previous studies
where other phenolics have also been reported to show neuroprotective effects including reducing the
oxidative stress induced cell death of neurons via modulation of caspase-3 activity [50]. These data
suggest that these common edible berries may have potential neuroprotective effects and that their
anthocyanins contribute, in part, towards these biological effects. However, the structural diversity of
the various anthocyanins found in these berries and the possible synergistic effects among themselves,
as well as with other “non-anthocyanin” phytochemicals may lead to differences in their biological
effects [51]. For instance, anthocyanin metabolism and bioavailability have been reported to be
influenced by differences in their chemical structure including the type of aglycone and their attached
moieties [51]. Therefore, the diverse structural varieties of the different anthocyanins present in these
six edible berries (see Figures S1A–S6A in the Supplementary Materials) could indeed influence their
potential neuroprotective effects. Also, anthocyanins have been reported to have synergistic effects
with other ‘non-anthocyanin’ phenolic compounds in their biological properties and the possibility of
other substances such as vitamins, minerals, and carbohydrates (oligosaccharides and polysaccharides)
in these berry extracts (see the summary of berry constituents in Supplementary Materials Table S1)
contributing toward their potential neuroprotective effects cannot be excluded. Lastly, given that
our evaluations were conducted using biophysical and in vitro assays, which are not translatable to
the in vivo situation, further studies using animal models are warranted to evaluate the potential
neuroprotective effects of these berries against AD [52,53].
4. Materials and Methods
4.1. Chemicals
Aminoguanidine hydrochloride (AG), bovine serum albumin (BSA), D-fructose, D-ribose,
2,3-dimethylquinoxaline (DQ), gallic acid (GA), resveratrol (RESV), butylated hydroxytoluene (BHT),
2,2-diphenyl-1-picrylhydrazyl (DPPH), methylglyoxal (MGO), 1,2-phenylenediamine (PD), hydrogen
peroxide (H2O2), trifluoroacetic acid (TFA), lipopolysaccharide (LPS), 2’,7’-dichlorofluorescin diacetate
reagent (DCFDA), XAD-16 Amberlite resin, and HPLC-grade methanol were purchased from
Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). Beta amyloid 1-42 (Aβ) was purchased from
AnaSpec Inc. (Fremont, CA, USA). Griess reagent was purchased from Promega Corp. (Madison,
MI, USA).
4.2. Berry Materials
Blackberry and black raspberry freeze dried powders were provided by Scenic Fruit Company
(Gresham, OR, USA) and Berri Products LLC (Corvallis, OR, USA), respectively. Strawberry freeze
dried powder was provided by the California Strawberry Commission (Watsonville, CA, USA).
Freeze dried red raspberry fruit was provided by the Washington Red Raspberry Commission from
HoneyVille Farms (Brigham City, UT, USA). Cranberry fruit powder was provided by Ocean Spray
Cranberries Inc. (Middleborough, MA, USA). Blueberry fresh fruit was purchased from a local Stop &
Shop grocery store (Narragansett, RI, USA).
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4.3. Preparation and Fractionation of Berry Extracts
Our laboratory has previously reported on the preparation and chemical characterization of
phenolic-enriched extracts from berries. [25,26,54–56] Therefore following these previously published
protocols, each berry sample (100 g for freeze dried berry powders; 250 g for blueberry fresh
fruit) was extracted with methanol (500 mL) to yield crude extracts (CEs) after solvent removal
in vacuo. The dried methanolic berry CEs were fractionated to yield anthocyanins-free (ACFs) and
anthocyanin-enriched (ACEs) extracts using XAD-16 Amberlite resin adsorption chromatography.
Briefly, each berry CE (10 g) was reconstituted in distilled water (200 mL) and adsorbed on to an
XAD-16 Amberlite resin column (300 mm × 3.5 mm, i.d.). After 4 h of adsorption time, the column
was eluted with distilled water (1 L) followed by methanol (1 L) to yield ACFs and ACEs, respectively,
for each berry, after solvent removal in vacuo. Based on our previously published study [12], and data
from our preliminary experiments, the concentrations of berry extracts used for the biophysical assays
were as follows: 100 µg/mL for the MGO trapping assay; 100 and 500 µg/mL for the BSA-fructose
assay and BSA-MGO assay, respectively; 100 and 400 µg/mL for the ThT Aβ fibrillation assay.
4.4. Total Phenolic and Anthocyanins Content
The total phenolic content for each berry sample (CEs, ACFs, ACEs) was determined using the
Folin–Ciocalteau method and expressed as gallic acid equivalents (GAEs) as previously reported [12].
Briefly, the berry samples (10–20 mg/mL) were diluted 1:100 with methanol/H2O (1:1, v/v). 100 µL
of each sample was incubated with 50 µL of Folin–Ciocalteau reagent for 5 min at room temperature
(25 ◦C). 150 µL Na2CO3 and 250 µL H2O were added to each sample and incubated at 40 ◦C in the dark
for 30 min. Samples were then cooled on ice to room temperature and centrifuged. The absorbance
was determined at 756 nm on a Spectramax M2 plate reader operated by SoftmaxPro v.4.6 software
(Molecular Devices, Sunnyvale, CA, USA). The total anthocyanins content was performed using the
pH differential method (expressed as cyanidin-3-O-glucoside equivalents) as previously reported [57].
Briefly, each berry sample was made to a stock solution (20 mg/mL). Two aliquots (1.0 mL) of the
stock solution were placed into 25 mL volumetric flasks which were then filled up to mark using
pre-prepared buffers of pH 1.0 or pH 4.5, respectively. The absorbance of these buffer solutions were
recorded at 510 and 700 nm, respectively, using a SpectraMax M2 plate reader (Molecular Devices,
Sunnyvale, CA, USA).
4.5. 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) Free Radical Scavenging Assay
The free radical scavenging capacities of the berry samples (CEs, ACFs, ACEs) were determined
by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay as previously reported [9].
The assay was performed in a 96-well plate using serial dilutions of 100 µL aliquots of each of the berry
samples (ranging from 0.2–5 mg/mL). DPPH solution (100 µL) was added to each well, and the plate
was incubated at room temperature in the dark for 30 min. The absorbance was determined at 517 nm
using a SpectraMax M2 plate reader.
4.6. Reactive Carbonyl Species (Methylglyoxal; MGO) Trapping Assay
The trapping capacity of reactive carbonyl species (RCS) by the berry samples (CEs, ACFs, ACEs)
was evaluated using the previously reported method [6]. Briefly, a reaction solution consisting of
MGO (5 mM), PD (derivatization reagent, 20 mM), and DQ (internal standard, 5 mM) were freshly
prepared in 0.1 M phosphate buffer, pH 7.4. The MGO solution (0.25 mL) was mixed with phosphate
buffer (0.25 mL) serving as a blank solution. Each berry sample (0.25 mL of 100 µg/mL) was added
to MGO (0.25 mL of 5 mM). After incubation at 37 ◦C for 1 h, PD and DQ (0.125 mL, each), were
added to each mixture. The solutions were then left at room temperature for 30 min. The amount
of 2-methylquinoxaline (2-MQ), the derivative of residual MGO, was quantified by HPLC-DAD as
previously reported [6].
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4.7. Inhibition of the Formation of Advanced Glycation Endproducts (AGEs)
The inhibition of formation of AGEs was determined using the BSA-fructose and BSA-MGO
intrinsic fluorescence methods as previously reported [7]. All solutions were prepared in 0.1 M
phosphate buffer of pH 7.4. Reaction mixtures consisted of 10 mg/mL of BSA and 100 mM of
D-fructose or 5 mM of MGO. Each berry samples (CEs, ACFs, and ACEs) were evaluated at low and
high concentrations of 100 and 500 µg/mL, respectively. For the BSA-fructose assay, the samples were
incubated at 37 ◦C for 21 days while for the BSA-MGO assay, the samples were incubated for 7 days.
After their respective incubation periods, all samples were transferred to a 96-well fluorescence reading
plate and the intrinsic fluorescence levels were measured at an excitation wavelength of 360 nm and
an emission wavelength of 430 nm using a Spectramax M2 plate reader.
4.8. Anti-Aβ Fibrillation Assay
The inhibitory effects on Aβ fibrillation by the berry ACEs were determined by the thioflavin T
(ThT) assay following previously reported methods with minor modifications [12]. Two protocols,
thermal-induced Aβ fibrillation and MGO-induced Aβ fibrillation, were followed. The final
concentrations of Aβ were adjusted to 50 µM. The berry ACEs were evaluated at low and high
concentrations of 100 and 400 µg/mL, respectively. For the thermal-induced assay, Aβ solutions
were incubated at 37 ◦C for 72 h while for the MGO-induced assay, 1 mM MGO was added to the
reaction mixture prior to incubation. Resveratrol (RESV; at 100 µg/mL) and aminoguanidine (AG;
at 100 µg/mL) served as the positive controls for the thermal-induced and MGO-induced assays,
respectively. After 72 h, 20 µL of each Aβ solution was mixed with 100 µL of 10 µM ThT solution and
the intrinsic fluorescence was determined on a SpectraMax M2 plate reader at excitation and emission
wavelengths of 450 and 490 nm, respectively.
4.9. Cell Culture
Murine BV-2 microglia were a kind gift from Grace Y. Sun (University of Missouri at Columbia,
MO, USA). Cells were maintained in 10% heat inactivated FBS, with 1% P/S (100 U/mL penicillin,
100 mg/mL streptomycin) in high glucose (4.5 g/L) DMEM/F-12 media at 37 ◦C in 5% CO2. The berry
ACEs were dissolved in distilled water to obtain stock solutions (10 mg/mL) and then diluted with
serum free media to yield final concentrations of 20 µg/mL. Control groups were treated with DMSO
(≤0.1%) in serum free media.
4.10. Effects of Berry ACEs on BV-2 Microglia Viability
The effects of each berry ACE on BV-2 microglia viability were determined by the Cell Titer Glo
(CTG 2.0) assay (Promega; Fitchburg, WI, USA) as previously reported by our laboratory [12]. In brief,
BV-2 cells were plated in 96-welled white wall, clear bottom plates at a density of 100,000 cells/mL in
DMEM/F-12 media. After a period of 24 h, medium was removed and replaced with each berry ACE
treatment (at 20, 40 and 80 µg/mL) for 24 h. Then cellular viability of BV-2 cells was assessed with
CTG 2.0 method by measuring luminescence with a SpectraMax M2 Plate Reader.
4.11. Measurement of Total Nitric Oxide Species (NOS) in BV-2 Microglia by Griess Assay
The production of total nitric oxide species (NOS) in BV-2 microglia was evaluated by the Greiss
reagent assay kit (Promega, Fitchburg, WI, USA) as previously reported by our laboratory [58]. Briefly,
BV-2 microglia were seeded in clear 24-well plates at 100,000 cells/mL in DMEM/F-12 media. Cells
were pre-treated with berry ACEs (at 20 µg/mL) for 1 h. Next, BV-2 microglia were exposed to
lipopolysaccharide (LPS; at 1 µg/mL) for 23 h. Culture media was then transferred to a 96-well plate
and measured for total NOS.
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4.12. Measurement of Reactive Oxygen Species (ROS) in BV-2 Microglia
Reactive oxygen species (ROS) in BV-2 microglia was determined using a fluorescent probe,
dichlorofluorescin diacetate (DCFDA), as previously reported by our laboratory [59]. BV-2 microglia
were seeded in black walled clear bottom 96-well plates at 100,000 cells/mL in DMEM/F-12 media.
The BV-2 microglia were incubated with each berry ACEs (at 20 µg/mL) for 24 h and then media
from the treatment groups was replaced with media containing DCFDA (20 µM). After incubation for
30 min, the DCFDA media was removed and cells were washed. Next, the BV-2 microglia were treated
with hydrogen peroxide (H2O2; at 100 µM) and then incubated for 6 h. The amounts of ROS in the
BV-2 cells were measured using a SpectraMax M2 Plate Reader at excitation and emission wavelengths
of 495 and 529 nm, respectively.
4.13. Measurement of Caspase-3/7 Activity in BV-2 Microglia after H2O2 Exposure
Caspase-3/7 activity was determined using a Caspase-Glo 3/7 assay kit (Promega, Fitchburg, WI,
USA) as previously described by our laboratory [60]. BV-2 microglia were pre-treated for 24 h with
each berry ACEs (at 20 µg/mL). Cells were then treated with hydrogen peroxide (H2O2; at 100 µM) for
6 h. After incubation, Caspase-Glo 3/7 assay was performed according to the manufacturer’s protocol.
4.14. Measurement of BV-2 Microglia Viability after Exposure to Hydrogen Peroxide (H2O2)
Cell viability was determined using the Cell Titer Glo (CTG 2.0) assay (Promega; Fitchburg, WI,
USA) as previously reported by our laboratory [12]. Briefly, BV-2 microglia were seeded in white
walled clear bottom 96-well plates at a density of approximately 100,000 cells/mL in DMEM/F-12
media. After incubation of 24 h for adhesion, the BV-2 microglia were treated with the berry ACEs
(at 20 µg/mL) for 24 h. Cell toxicity was then induced by exposure of the cells to hydrogen peroxide
(H2O2; at 100 µM). After 6 h incubation, cellular viability was determined by the CTG 2.0 assay on a
SpectraMax M2 Plate Reader. Cell viability was reported as a percent of vehicle control (DMSO).
4.15. Statistical Analysis
The DPPH assay, MGO trapping assay, anti-glycation, and ThT assays were performed
in at least three replicates for each sample. In the fluorescence reading assays (anti-glycation
and ThT assays), the inhibition rate (% inhibition) was defined using the following equation:
% inhibition = [1 − (fluorescence intensity of solution with treatment/fluorescence intensity of control
solution)] × 100%. The cellular assays were conducted as three independent experiments each with
three replicates per sample and the values presented herein were chosen from one of these experiments
with three replicates for each sample. Data were reported as mean ± standard deviation (SD) with an
n = 3. Statistical significance was determined using One-Way Analysis of Variance with corrections for
multiple comparisons using Dunnett’s Test using Graphpad Prism Software (La Jolla, CA, USA).
5. Conclusions
In summary, six common edible berries including blackberry, black raspberry, blueberry, cranberry,
red raspberry, and strawberry were evaluated in a panel of bioassays for their potential anti-glycation
and neuroprotective effects. The berry CEs, ACFs, and ACEs showed free radical scavenging,
MGO-trapping, and anti-glycation effects. Given the higher phenolic contents and biological effects
of the berry ACEs in these assays, they were selected for further evaluation for their potential
neuroprotective effects in the anti-Aβ fibrillation and BV-2 microglia bioassays. The berry ACEs
inhibited the fibrillation of Aβ in both thermal- and MGO-induced models, reduced LPS- and
H2O2-induced inflammatory and oxidative stresses in BV-2 microglia, increased BV-2 cell viability
against H2O2–induced oxidative stress induced cytotoxicity, and decreased the activity of an apoptotic
protease (capase-3/7) in BV-2 cells. These data suggest that these common edible berries may have
potential microglial neuroprotective effects and that their anthocyanins contribute, in part, towards
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these biological effects. However, given that these studies were conducted using biophysical and
in vitro assays, which are not translatable to the in vivo situation, further studies using in vivo models
are warranted to evaluate the potential effects of these berries against AD.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/19/2/461/s1.
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Abbreviations
AGEs advanced glycation endproducts
Aβ beta amyloid
AD Alzheimer’s disease
ACE anthocyanins-enriched extract
ACF anthocyanins-free extract
AG aminoguanidine
BHT butylated hydroxytoluene
BSA bovine serum albumin
CE crude extract
GAE gallic acid equivalent
LPS lipopolysaccharide
MGO methylglyoxal
NOS nitric oxide species
RCS reactive carbonyl species
ROS reactive oxygen species
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